Shrinking lung syndrome: Recognition, pathophysiology and therapeutic strategy

Expert Review of Respiratory Medicine

Volumn 5, Issue 1, 2011, Pages 33-39

  Carmier, Delphine ^a   Diot, Elisabeth ^a   Diot, Patrice ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

autoimmune diseases; diaphragm; respiratory muscles; shrinking lung syndrome; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; RO ANTIBODY; STEROID; THEOPHYLLINE;

ARTICLE; ATELECTASIS; BIOLOGICAL THERAPY; BREATHING MUSCLE; COMPUTER ASSISTED TOMOGRAPHY; DIAPHRAGM; DIAPHRAGM DISEASE; DIAPHRAGMATIC FATIGUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DYSPNEA; FORCED EXPIRATORY VOLUME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPATHOGENESIS; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG PARENCHYMA; LUNG VOLUME; LUPUS ERYTHEMATOSUS NEPHRITIS; MYOPATHY; PATHOGENESIS; PATHOPHYSIOLOGY; PERICARDITIS; PHRENIC NERVE; PLEURAL FIBROSIS; PLEURISY; POLYMYOSITIS; PREVALENCE; PROGNOSIS; SHRINKING LUNG SYNDROME; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYPNEA; THORAX PAIN; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

EID: 79952154662     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.10.84     Document Type: Article

References (49)

1. Hoffbrand BI, Beck EI. Unexplained dyspnoea and shrinking lungs in systemic lupus erythematosus. Br. Med. J. 1, 1273-1277 (1965).
2. Gibson GJ, Edmonds JP, Hughes GR. Diaphragm function and lung involvement in systemic lupus erythematosus. Am. J. Med. 63, 926-932 (1977). (Pubitemid 8251834)
3. Thompson PJ, Dhillon DP, Ledingham J et al. Shrinking lungs, diaphragmatic dysfunction and systemic lupus erythematosus. Am. Rev. Respir. Dis. 132, 926-928 (1985).
4. Warrington KJ, Moder KG, Brutinel WM. The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin. Proc. 75, 467-472 (2000). (Pubitemid 30252370)
5. Branger S, Schleinitz N, Gayet S et al. Le syndrome des poumons rétractés et les maladies immunes. Rev. Med. Interne. 25, 83-90 (2004). (Pubitemid 38229172)
6. Karim MY, Miranda LC, Tench CM et al. Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin. Arthritis Rheum. 31, 289-298 (2002). (Pubitemid 34415254)
7. Traynor AE, Corbridge TC, Eagan AE et al. Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: improvement correlates with disease remission following hematopoietic stem cell transplantation. Chest 127, 1680-1689 (2005). (Pubitemid 46218795)
8. Toya SP, Tzelepis GE. Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic review. Semin. Arthritis Rheum. 39, 30-37 (2009).
9. Singh R, Huang W, Menon Y et al. Shrinking lung syndrome in systemic lupus erythematosus and Sjogrens syndrome. J. Clin. Rheumatol. 8, 340-345 (2002). (Pubitemid 35453603)
10. Tavoni A, Vitali C, Cirigliano G et al. Shrinking lung syndrome in primary Sjögrens syndrome. Arthritis Rheum. 42, 2249-2250 (1999).
11. Ahmed S, Herrick A, ODriscoll BR. Shrinking lung syndrome in patients without systemic lupus erythematosus: comment on the consice communication by Tavoni et al. Athritis Rheum. 44, 243-245 (2001). (Pubitemid 32113144)
12. Dauriat G, Stern JB, Similowski T et al. Acute respiratory failure due to diaphragmatic weakness revealing a polymyositis. Eur. Inter. Med. 13, 203-205 (2002). (Pubitemid 34518513)
13. Teixeira A, Chérin P, Demoule A et al. Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscular Disorders 15, 32-39 (2005). (Pubitemid 41556630)
14. Laroche CM, Mulvey DA, Hawkins PN et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med. 71, 429-439 (1989). (Pubitemid 19161767)
15. Pego-Reigosa JM, Medeiros DA, Isenberg DA. Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Pract. Res. Clin. Rheumatol. 23, 469-480 (2009).
16. Allen D, Stoller JK, Minai OA. A 45-year-old woman with systemic lupus erythematosus and progressive dyspnea. Chest 131, 1252-1255 (2007). (Pubitemid 46608736)
17. Carmier D, Marchand-adam S, Diot P et al. Atteinte respiratoire au cours du lupus érythémateux systémique. Rev. Mal. Resp. 25, 1289-303 (2008).
18. Jacobelli S, Moreno R, Massardo L et al. Inspiratory muscle dysfunction and unexplained dyspnea in systemic lupus erythematosus. Arthritis Rheum. 28, 781-788 (1985). (Pubitemid 15027332)
19. Cavallesca JA, Dubinsky D, Nasswetter GG. Shrinking lungs syndrome, a rare manifestation of systemic lupus erythematosus. Int. J. Clin. Pract. 60, 1683-1686 (2006). (Pubitemid 44752509)
20. Ishii M, Uda H, Yamagami T, Katada Y. Possible association of shrinking lung and anti-Ro/SSA antibody. Arthritis Rheum. 43, 2612-2613 (2000).
21. Munoz-Rodriguez FJ, Font J, Badia RJ et al. Shrinking lung syndrome in systemic lupus erythematosus: improvement with inhaled b-agonist therapy. Lupus 6, 412-414 (1997). (Pubitemid 27232139)
22. Kitamura Y, Okano Y. A case of shrinking lung syndrome in SLE: improvement with corticosteroid therapy. Nihon Rinsho Meneki Gakkai Kaishi 19, 217-222 (1996).
23. Al Arfaj AS, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 18, 465-473 (2000).
24. Soubrier M, Dubost JJ, Piette JC et al. Shrinking lung syndrome in systemic lupus erythematosus. A report of three cases. Rev. Rhum. Engl. Ed. 62, 395-398 (1995).
25. Mills GH, Kyroussis D, Hamnegard CH et al. Cervical magnetic stimulation of the phrenic nerves in bilateral diaphragm paralysis. Am. J. Respir. Crit. Care Med. 155, 1565-1569 (1997). (Pubitemid 27216659)
26. Mador MJ, Khan S, Kufel TJ. Bilateral anterolateral magnetic stimulation of the phrenic nerves can detect diaphragmatic fatigue. Chest 121, 452-458 (2002). (Pubitemid 34132982)
27. Hawkins P, Davidson AG, Dasgupta B et al. Diaphragm strength in acute systemic lupus erythematosus in patients with paradoxical abdominal motion and reduced lung volumes. Thorax 56, 329-330 (2001). (Pubitemid 32269818)
28. Fergusson PJ, Weinberger M. Shrinking lung sysdrome in a 14 year old boy with systemic lupus erythematosus. Pediat. Pulmonol. 41, 194-197 (2006). (Pubitemid 43165451)
29. Hardy K, Herry I, Attali V et al. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 119, 1274-1277 (2001). (Pubitemid 32679461)
30. Wilcox PG, Stein HB, Clarke SD et al. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest 93, 352-358 (1988). (Pubitemid 18053076)
31. Oud KT, Bresser P, Ten Berge RJ et al. The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy. Lupus 14, 959-963 (2005). (Pubitemid 43088270)
32. Keane MP, Lynch JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 55, 159-166 (2000). (Pubitemid 30245959)
33. Ropes MW. Systemic Lupus Erythematosus. Harvard University Press, MA, USA (1976).
34. Montes JF, Garcia-valero J, Ferrer J. Evidence of innervation in talc induced pleural adhesions. Chest 130, 702-709 (2006). (Pubitemid 44423600)
35. Walz-Leblanc BAE, Urowitz MB, Gladman DD et al. Shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy. J. Rheumatol. 19, 1970-1972 (1992). (Pubitemid 23018534)
36. Martens J, Demadts M, Vanmeenen MT et al. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 84, 170-175 (1983). (Pubitemid 13027154)
37. Aubier M. Effects of theophylline on diaphragmatic muscle function. Chest 92, 27S-31S (1987). (Pubitemid 17098800)
38. Van Veen S, Peeters AJ, Sterk PJ et al. The shrinking lung syndrome in SLE, treatment with theophylline. Clin. Rheumatol. 12, 462-465 (1993). (Pubitemid 24021286)
39. Ernest D, Leung A. Ventilatory failure in shrinking lung syndrome is associated with reduced chest compliance. Intern. Med. J. 40, 66-69 (2010).
40. Lu TY, Cambridge G, Leandro MJ et al. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Arthitis Rheum. 61, 482-487 (2009).
41. Leandro MJ, Cambridge G, Edwards JC et al. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) 44, 1542-1545 (2005). (Pubitemid 41742472)
42. Gottenberg JE, Guillevin L, Lambotte O et al. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune disease. Ann. Rheum. Dis. 64, 913-920 (2005). (Pubitemid 40733918)
43. Butterly SJ, Pillans P, Horn B. Off-label use of rituximab in a tertiary Queensland hospital. Intern. Med. J. 40, 443-452 (2010).
44. Benham H, Garske L Vecchio P et al. Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus. J. Clin. Rheumatol. 16, 68-70 (2010).
45. Merrill JT, Neuwelt CM, Wallace DJ et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, Phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 62, 222-233 (2010).
46. Furie R, Looney RJ, Rovin B et al. Efficacy and safety of rituximab in subjects with active proliferative lupus nephritis (LN): results from the randomized, double-blind Phase III LUNAR study (abstract). Arthritis Rheum. 60(Suppl.), S429 (2010).
47. Terrier B, Amoura Z, Ravaud PH et al. Safety and efficacy of rituximab in systemic lupus erythematosus. Results from 136 patients from the French Autoimmunity and Rituximab Registry. Arthritis Rheum. 62, 2458-2466 (2010).
48. Vilaplan-Garcia, Trujillo-Santos AJ, Vera-Mendez FJ. Shrinking lung syndrome, a rare manifestation of systemic lupus erythematosus. Arch. Bronconeuromol. 44, 341-342 (2008).
49. Elkayan O, Segal R, Caspi D et al. Restrictive lung disease due to diaphragmatic dysfunction in systemic lupus erythematosus. Two cases reports. Clin. Exp. Rhumatol. 10, 267-269 (1992).